- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05885906
Aloe Vera Versus Thyme Honey Mouthwash in Management of Xerostomia in Type 2 Diabetics
Aloe Vera Versus Thyme Honey Mouthwash in Management of Xerostomia in Type 2 Diabetics (A Randomized Controlled Clinical Trial With Biochemical Analysis)
The objectives of the present study are to:
- Compare the clinical efficacy of (50%) aloe vera versus (20%) thyme honey mouthwash on management of xerostomia in diabetic patients by measuring the salivary flow rate as a primary objective.
- Asses the biochemical effect of aloe vera and thyme honey on the level of salivary nitric oxide, xerostomia grade as well as patient quality of life as a secondary objective.
Research question:
Which is better aloe vera or thyme honey in improving salivary flow rate in diabetic patients suffering from xerostomia?
Patient Grouping and Randomization:
Patients with xerostomia will be randomly distributed into three groups using a computer-generated randomization table. Allocation concealment will be achieved by a sealed opaque envelope with a ratio of 1:1:1
Group 1 (Aloe Vera group)
Include (15) patient suffering from diabetes induced xerostomia that will receive aloe vera as mouthwash
Group 2 (Thyme honey group):
Include (15) patient suffering from diabetes induced xerostomia that will receive thyme honey mouthwash
Group 3 (Saline control group):
Include (15) patient suffering from diabetes induced xerostomia that will receive saline mouthwash
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt
- Faculty of Dentistry Ain Shams university
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Both gender, with type 2 diabetes mellitus only and suffering from xerostomia.
- Patients willing to follow all the instructions and attend all the study-associated visits.
Exclusion Criteria:
- Patients who had received radiation therapy to the head and neck region.
- Patients with other systemic diseases known to cause xerostomia (Sjogren's syndrome, rheumatoid arthritis, systemic lupus erythematosus, hepatitis C virus, tuberculosis, or sarcoidosis).
- Patients using any other medication for their dry mouth condition (pilocarpine, cevimeline) 7 days before entering into the study.
- Patients requiring hospitalization for any medical problem during the study.
- Known hypersensitivity to the active ingredient of the product that will be used as assessed by the medical history questionnaire.
- Vulnerable groups such as mentally or physically handicapped individuals, pregnant females, prisoners.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Aloevera group
15 patients suffering from diabetes induced xerostomia that will receive aloe vera as mouthwash (20 ml of aloe vera 50%) 3 times per day for 4 weeks.
|
Mouthwash
|
|
Active Comparator: Thyme honey group
15 patients suffering from diabetes induced xerostomia that will receive thyme honey mouthwash (20 ml of thyme honey diluted in 100 ml of distilled water) 3 times per day for 4 weeks.
|
Mouthwash
|
|
Placebo Comparator: Saline group
15 patients suffering from diabetes induced xerostomia that will receive saline mouthwash as a control group (20 ml of saline) 3 times per day for 4 weeks.
|
Mouthwash
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in unstimulated Salivary flow rate
Time Frame: Baseline, 2weeks and 4weeks
|
Milliliters
|
Baseline, 2weeks and 4weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Radwa Rageb, PHD, Ain Shams University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FDASU-RecIM122208
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Xerostomia
-
University of BrasiliaNot yet recruitingXerostomia Following Radiotherapy
-
Bedford Hospital NHS TrustUnknownXerostomia | Xerostomia Due to Radiotherapy | Xerostomia Due to Hyposecretion of Salivary Gland
-
Poznan University of Medical SciencesEnrolling by invitationXerostomia Due to Hyposecretion of Salivary GlandPoland
-
Laboratoires CARILENEDERMSCAN-PHARMASCAN GROUP in charge of data analysisCompleted
-
MeiraGTx, LLCActive, not recruitingRadiation-induced XerostomiaUnited States, Canada
-
Thomas KuhntVerband Deutscher DruckkammerzentrenTerminatedRadiation-induced XerostomiaGermany
-
Alexandria UniversityRecruitingRadiation Induced XerostomiaEgypt
-
Institute of Oncology LjubljanaUniversity Medical Centre Ljubljana; University of Ljubljana; Blood Transfusion...Not yet recruitingXerostomia Following RadiotherapySlovenia
-
Catholic University of the Sacred HeartSunstar Italiana SRL.CompletedXerostomia | Xerostomia Following RadiotherapyItaly
Clinical Trials on Aloevera
-
Kamedis Ltd.UnknownRadiation DermatitisIsrael
-
Sheba Medical CenterFerring PharmaceuticalsCompleted
-
The Oxford Dental College, Hospital and Research...CompletedOral SubMucous Fibrosis
-
Government Dental College and Research Institute...Completed
-
Mansoura UniversityRecruiting
-
Universitas DiponegoroRecruitingBPH (Benign Prostatic Hyperplasia)Indonesia